Gambaran Hasil Pemeriksaan Tes Cepat Molekuler Mycobacterium Tuberculosis pada Pasien Terduga Tuberkulosis di Kabupaten Sleman
DOI:
https://doi.org/10.57213/medlab.v5i2.536Keywords:
Tuberculosis, Tuberculosis ScreeningAbstract
Tuberculosis remains one of the major infectious diseases in Indonesia and continues to contribute significantly to morbidity and mortality rates. Rapid and accurate diagnosis is essential to reduce transmission and improve treatment outcomes. Molecular Rapid Test (MRT) or GeneXpert MTB/RIF has been widely implemented as a diagnostic tool capable of detecting Mycobacterium tuberculosis and rifampicin resistance simultaneously within a short time. This study aimed to describe the results of Molecular Rapid Test examinations among presumptive tuberculosis patients at RSUD Prambanan, Sleman Regency. This research used a descriptive observational design with secondary data obtained from TB 04 records and the Tuberculosis Information System (SITB) during January–December 2025. A total of 2,384 samples fulfilled the inclusion criteria and were analyzed descriptively using frequency distribution and percentages. The results showed that most patients belonged to the low-risk category (96.9%), while only 3.1% were classified as high-risk. Most examination results indicated MTB not detected in both groups. Rifampicin-sensitive MTB was identified in 153 patients, whereas rifampicin-resistant MTB was found in only one patient. Positive MTB results were more frequently identified in male patients and adult-to-elderly age groups. The study concludes that most presumptive tuberculosis patients examined using GeneXpert showed MTB not detected results with a very low prevalence of rifampicin resistance. These findings support the importance of maintaining early detection programs and strengthening tuberculosis control strategies in healthcare facilities.
References
Anggraeni, R., Sijid, S. A., & Commeng, A. T. (2024). Deteksi Mycobacterium tuberculosis melalui pemeriksaan tes cepat molekuler (TCM) di Balai Besar Laboratorium Kesehatan Makassar. Teknosains: Media Informasi Sains dan Teknologi, 18(1), 57–64. https://doi.org/10.24252/teknosains.v18i1.42692
Arisandi, M., Novitry, F., Masyarakat, K., & Al-Ma’arif Baturaja, S. (2024). Faktor yang berhubungan dengan kejadian tuberkulosis di rumah sakit umum daerah. Lentera Perawat, 5(1). https://doi.org/10.52235/lp.v5i1.284
Burhan, E., Karyana, M., Karuniawati, A., Kusmiati, T., Wibisono, B. H., Handayani, D., Riyanto, B. S., Sajinadiyasa, I. G. K., Sinaga, B. Y. M., Djaharuddin, I., Sugiyono, R. I., Susanto, N. H., Diana, A., Kosasih, H., Lokida, D., Siswanto, Neal, A., Lau, C. Y., & Siddiqui, S. (2022). Characteristics of drug-sensitive and drug-resistant tuberculosis cases among adults at tuberculosis referral hospitals in Indonesia. The American Journal of Tropical Medicine and Hygiene, 107(5), 984–991. https://doi.org/10.4269/ajtmh.22-0142
Chabaria, E., Perdani, R., & Pratiwi, W. (2024). Gambaran hasil pemeriksaan tes cepat molekuler (TCM) pada pasien suspek tuberkulosis paru di RSUD Ulin Banjarmasin tahun 2023. Jurnal Elektronik Mahasiswa Polanka, 1(2). http://jurnal.polanka.ac.id/index.php/JMPL
Hartiyah, L., & Santoyo, D. (2023). Gambaran hasil pemeriksaan tes cepat molekuler Mycobacterium tuberculosis di RSUD Ulin Banjarmasin tahun 2020–2021. https://doi.org/10.20527/ht.v6i1.8791
Hiddayaturrahmi, H., Zahra, H., Faisal, F., & Irwandi. (2024). Gambaran pelaksanaan program penanggulangan tuberkulosis di Dinas Kesehatan Kota Solok tahun 2024. Sciena Scientific Journal, 3(5). https://doi.org/10.56260/sciena.v3i5.171
Jasmin, M., Risnawati, Rahmah Siregar, R., Rahmah, M., Rohmawati, W., Handayani, L., Ronald, Ridwan, B. A., Sarasmita, M. A., Febriyanti, H., Juliastuti, D., Fika Tri Anggraini, Yusnita Anggraeni, & Oktari, S. (2023). Metodologi penelitian kesehatan. CV Eureka Media Aksara.
Lestari, B. W., Nijman, G., Larasmanah, A., Soeroto, A. Y., Santoso, P., Alisjahbana, B., Chaidir, L., Andriyoko, B., van Crevel, R., & Hill, P. C. (2024). Management of drug-resistant tuberculosis in Indonesia: A four-year cascade of care analysis. The Lancet Regional Health – Southeast Asia, 22, Article 100294. https://doi.org/10.1016/j.lansea.2023.100294
Nasywa, Y., Suharti, N., & Katar, Y. (2022). Sensitivitas dan spesifisitas GeneXpert pada sputum pasien suspek tuberkulosis paru. Jurnal Ilmu Kesehatan Indonesia, 3(2), 125–130. https://doi.org/10.25077/jikesi.v3i2.839
Pradnyani, P. E., Hasibuan, S. R., & Putra, G. W. (2025). The association between sociodemographic factors and the return visits among pediatric tuberculosis patients at primary health care facilities in DKI Jakarta Province. Jurnal Ilmu Kesehatan Masyarakat, 17(1), 12–13. https://doi.org/10.26553/jikm.2026.17.1.12
Putri Kusumandari, V., & Nawangsari, D. (2023). Pengaruh riwayat pengobatan pasien TB terhadap kejadian TB MDR di RSUD Prof. Dr. Margono Soekarjo. Pharmagen, 2(3). https://doi.org/10.56359/pharmgen.v2i3.294
Rahayu, A., Rovik, A., & Turnip, O. N. (2024). Current understanding of Mycobacterium tuberculosis drug resistances and diagnostics in Indonesia: A review. Journal of Experimental and Clinical Pharmacy, 4(2), 129–136. https://doi.org/10.52365/jecp.v4i2.1121
Rahman, I. W., Arfani, N., Faisal, M. W., Kesrianti, A. M., Fadlila, R. N., & Rantisari, A. M. D. (2022). Analisis mutasi gen rpoB sebagai penanda resistensi rifampisin pada penderita tuberkulosis paru di BBKPM Makassar. Sang Pencerah: Jurnal Ilmiah Universitas Muhammadiyah Buton, 8(2), 353–362. https://doi.org/10.35326/pencerah.v8i2.1836
Rahman, S. M. D., Sijid, S. A., & Hidayat, K. S. (2023). Pemanfaatan tes cepat molekuler (TCM) GeneXpert sebagai alat diagnostik TB paru di Balai Besar Kesehatan Paru Masyarakat Makassar (BBKPM). Filogeni: Jurnal Mahasiswa Biologi, 3(1), 55–59. https://doi.org/10.24252/filogeni.v3i1.29561
Ralfiansha, M., Afifah, A. N., Akaputra, R., & Farsida. (2023). Gambaran faktor-faktor tuberkulosis paru pada lansia di wilayah kerja Puskesmas Pisangan, Ciputat Timur periode Januari 2022–Oktober 2023. Prosiding Seminar Nasional Penelitian. http://jurnal.umj.ac.id/index.php/semnaslit
Sari, S., Ernia, R., Nabil, M., & Sitindaon, R. S. (2025). Gambaran hasil pemeriksaan tuberkulosis paru dengan menggunakan metode tes cepat molekuler (TCM) di Puskesmas 7 Ulu Kota Palembang tahun 2022. Jurnal Analis Kesehatan Klinikal Sains, 13(1). http://jurnal.univrab.ac.id/index.php/klinikal
Susanti, E. L., Hasnaini, A., & Murniaty. (2024). Karakteristik dan analisis risiko kasus tuberkulosis di Puskesmas Senen Jakarta Pusat tahun 2023. Jurnal Epidemiologi Kesehatan Indonesia, 8(2). https://doi.org/10.7454/epidkes.v8i2.1130
Tamtyas, F. I., & Rini, C. S. (2020). The detection of TB lungs with microscopic and the rapid molecular test methods. Medicra: Journal of Medical Laboratory Science/Technology, 3(1), 1–4. https://doi.org/10.21070/medicra.v3i1.650
Van Dinh, L., Tran, K. T., Codlin, A. J., Vo, L. N. Q., Nguyen, N. T. T., Nguyen, L. P., Forse, R., Nguyen, H. T., Dang, T. M. H., Nguyen, L. H., Nguyen, H. B., & Creswell, J. (2025). Prevalence of Xpert MTB/RIF Ultra trace call results and associated risk factors during active tuberculosis case finding in Viet Nam: A programmatic evaluation. Diagnostics, 15(8). https://doi.org/10.3390/diagnostics15081006
Wati, N., Aulia, I., Mu’awanah, U., & Amalia, A. A. (2024). Pulmonary tuberculosis incidence rate with GeneXpert examination method at Mlati II Public Health Center, Sleman in 2020–2023. International Journal of Health, Economics, and Social Sciences, 6(4), 1124–1129. https://doi.org/10.56338/ijhess.v6i4.6194
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Medical Laboratory
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
